Spitalul Clinic Judetean De Urgenta Cluj — Clinical Trial Site

95 Registered trials

36 Currently recruiting

Organisation

Spitalul Clinic Judetean De Urgenta Cluj

Location

Cluj-Napoca, Romania

Identifier

ORG-100042554

Address

Strada Profesor Victor Babes 43, 400012, Romania

Departments

#2173: Rheumatology
#3221: Diabetes
#3302:Rheumatology
#3700: Rheumatology
1102:Rheumatology
3002: Internal Medicine
3302; Rheumatology
3700: Rheumatology
3702: Ophthalmology
6002: Rheumatology
6102:Internal Medicine
642001: Internal Medicine
9007: Rheumatology
AEM with County Hosp. Cluj Napoca, Ophtalm. Build. 1st floor, Wrds 33,34,35, Clinicilor St
Arensia Exploratory Medicine at Spitalul Clinic Județean de Urgență Cluj
ATI
Cardiology
Cardiology and Internal Medicine
Centrul Clinic Judetean de Diabet Zaharat, Nutritie si Boli Metabolice
Clinica Medicala II
Clinical Department of Nephrology
Departament Clinic Oncologie Medicala
Dermatology
Dermatovenerology
Diabet zaharat, nutritie si boli metabolice
Endocrinology
Endocrinology Department
Gastroenterologie
Gastroenterology
Gastroenterology Department
Internal Medicine
Internal Medicine 3
Internal Medicine II Department
Internal Medicine III
Medical
Medical Department
Medical II
N/A
Neurologie
Neurology
Neurology Clinic
Neurology II
Oncology
Ophtalmology building, 1st floor, wards 33, 34, 35
Ophtalmology building, Wards 33, 34, 35
Ophthalmology Building
Ophthalmology Building, 1st floor, wards 33, 34, and 35
Ophthalmology Building, 1st floor, wards: 33, 34, 35
Ph.I Unit-AEM in collab. with County Emg. Hospital Cluj Ophthalm. build., 1st fl, wrds 33,34,35
Phase1Unit AEM, Spitalul Clinic Judetean De Urgenta Cluj in colab with ARENSIA CLINICS S.R.L
Psihiatrie
Pulmonology
Rheumatology
Rheumatology Department
Sectia Clinica de Neonatologie I
Sectia Clinica Medicina Interna III
Sectia Clinica Neurologie II
Sectia Medicina Interna III
Sectia Nefrologie
Sectia Neurologie I
Secţia Oncologie Medicală
Sectia Reumatologie

Clinical trials at this site (95)

Search interface

Phase 3 Study of Telitacicept in Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) Not authorised

2024-512716-21-00 Moderately to Severely Active Systemic Lupus Erythemato 5
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown

2025-523766-25-00 Ulcerative colitis 5
A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of Orally Administered DF-006 to Evaluate the Safety, Tolerabi… Pending

2023-504288-18-00 Chronic Hepatitis B 3
A study to compare the relative potency of salbutamol administered via metered dose inhalers containing propellants HFA-152a to HFA-134a in … Pending

2024-511220-14-00 Mild Asthma 3
A Participant- and Investigator--Blinded, Placebo-Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate… Pending

2025-520978-18-00 Chronic Kidney Disease 1
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants Pending

2025-521758-40-00 Geographic Atrophy 1
Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis Pending

2025-523678-17-00 rheumatoid arthritis 3
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio… Pending

2025-523704-77-00 Geographic atrophy secondary to age-related macular deg 4
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy o… Pending

2025-525113-22-00 Rheumatoid Arthritis 1
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight and type 2 diabetes Recruiting

2025-523106-32-00 Obesity or Overweight and Type 2 Diabetes 5 2026-05-25
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
A Multi-Stage Study to Test a New Drug in Healthy Adult Volunteers, Then in Adults with Ulcerative Colitis Recruiting

2025-522702-21-00 Ulcerative Colitis is a type of inflammatory bowel dise 4 2026-01-26
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a… Recruiting

2024-520196-27-00 Rheumatoid Arthritis 3 2025-10-01
A randomized, placebo-controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with… Recruiting

2024-516616-24-00 Acromegaly 5 2025-07-23
A phase 1 trial to evaluate the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in participants with … Recruiting

2024-518976-30-00 Systemic lupus erythematosus 3 2025-07-02
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults with… Recruiting

2024-513965-38-01 Sjögren's Disease 5 2025-06-16
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a… Recruiting

2023-505172-29-00 Resectable Non-small Cell Lung Cancer 4 2025-04-24
Study of GS-1427 in Participants With Moderately to Severely Active UC Recruiting

2023-508304-38-00 Ulcerative Colitis (UC) 4 2024-09-10
A Phase 3 Study to Investigate the Efficacy and Safety of Brepocitinib in Adults with Dermatomyositis Recruiting

2022-500367-12-00 Dermatomyositis 5 2022-11-30
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P… Recruiting

2024-514617-35-00 Progressive forms of Multiple Sclerosis 4 2021-12-20
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus E… Recruiting

2025-523552-31-00 Systemic Lupus Erythematosus 5 2026-05-07
A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004) Recruiting

2025-523412-36-00 Systemic lupus erythematosus, Rheumatoid arthritis 3 2026-02-17
Efficacy and Safety of IMVT-1402 in Adult Participants with Primary Sjogren’s Disease with Moderate to Severe Systemic Disease Activity Recruiting

2025-520831-18-00 Primary Sjogren’s Disease 4 2025-12-12